載入...
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Advanced renal cell carcinoma (RCC) remains a challenging, major health problem. Recent advances in understanding the fundamental biology underlying one form of RCC, ie, clear cell (or conventional) RCC, have opened the door to a series of targeted agents, such as the tyrosine kinase inhibitors (TKI...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921256/ https://ncbi.nlm.nih.gov/pubmed/20714356 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|